Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fibronectin 1: A Potential Biomarker for Ovarian Cancer

22 May 2021

Abstract excerpt

Object. Ovarian cancer is one of the most common cancers among females with high mortality rate, due to most patients diagnosed at the advanced stage of the disease. Seeking new biomarkers for ovarian cancer detection and progress indication is really important for the patients. Methods. OVCAR3 and A2780 are the two common cell lines that are used for ovarian cancer studies. The different invasion and migration...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Extracellular vesicles in disease
Share to Cell Adhesion Molecules Research
Share to Cellular Mechanics and Interactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34093898
DOI: 10.1155/2021/5561651

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fibronectin 1: A Potential Biomarker for Ovarian CancerPMID 34093898Read ↗

FN1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Thyroid Carcinoma and Breast Invasive CarcinomaSemantic proximity Read ↗

Overexpression of FNDC1 Relates to Poor Prognosis and Its Knockdown Impairs Cell Invasion and Migration in Gastric CancerSemantic proximity Read ↗

High expression of fibronectin 1 indicates poor prognosis in gastric cancerSemantic proximity Read ↗

SOX2 Targets Fibronectin 1 to Promote Cell Migration and Invasion in Ovarian Cancer: New Molecular Leads for Therapeutic InterventionSemantic proximity Read ↗

The Role of the Plasminogen Activator Inhibitor 1 (PAI1) in Ovarian Cancer: Mechanisms and Therapeutic ImplicationsSemantic proximity Read ↗

A Novel Clinical Nomogram for Predicting Lymph Node Metastasis in Ovarian Cancer: A SEER Analysis and External Validation in a Tertiary CenterSemantic proximity Read ↗

N2-neutrophils promote invasion and metastasis of ovarian cancer by upregulating MAPK signalingSemantic proximity Read ↗

The overexpression of EPS8L1 upregulates TIAM2 to promote cytoskeleton remodeling by activating the Rac1/MAPK signaling pathway in the migration of ovarian cancerSemantic proximity Read ↗

Effects of PELP1 on proliferation,metastasis and angiogenesis of epithelial ovarian cancerSemantic proximity Read ↗

High expression of COL1A1 exaggerates bone metastasis in estrogen receptor-positive (ER+) breast cancer and is potential to serve as a novel therapeutic targetSemantic proximity Read ↗

Exploring the mechanism of fibronectin extra domain B in the tumor microenvironment and implications for targeted immunotherapy and diagnostics (Review)Semantic proximity Read ↗

Trefoil factor 1 elevates the malignant phenotype of mucinous ovarian cancer cell through Wnt/β-catenin signaling.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.